Puriblood Medical Co., Ltd. developed a technology for blood cell separation that is supported by a research center R&D center for membrane technology RDCMT. PuriBlood is committed to improving the blood filtration process with innovative technology of ‘Zwitterionic bias Surface Coating Technology ZISC technology The company was founded by Dr. Yung Chang in 2016 and is headquartered in Hsinchu, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company